Abstract
Stroke is a devastating disease that is a leading cause of death and disability in developed countries. However, therapeutic options are notably limited, so is mandatory to investigate repairing processes after stroke in order to develop therapeutic strategies able to promote brain repair processes. In this context, therapeutic angiogenesis and vasculogenesis hold promise to improve the prognosis of patients with stroke. In this regard, it is well established that circulating endothelial progenitor cells (EPCs) have been suggested to be a marker of vascular risk and endothelial function. Moreover, low EPC number has been found in patients with cerebrovascular diseases. Besides, EPC levels have been associated with good neurological and functional outcome as well as reduced infarct growth in patients with acute ischemic stroke. Finally, experimental and clinical studies indicate that EPC might mediate endothelial cell regeneration and neovascularization. Therefore, EPC-based therapy could be an excellent therapeutic option in stroke. Currently, clinical trials for evaluating EPC treatment in ischemic stroke are ongoing. In this chapter, we discuss the present status of knowledge about the possible therapeutic role of EPCs in stroke, molecular mechanisms, and the future perspectives and strategies for their use in clinical practice.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- Ang-1:
-
Angiopoietin 1
- Cdc42:
-
Cell division control protein 42 homolog
- CFU-EC:
-
Early outgrowth colony forming unit-endothelial cell
- eF2:
-
Elongation factor 2
- Enos:
-
Endothelial nitric oxide synthase
- EPCs:
-
Endothelial progenitor cells
- EPO:
-
Erythropoietin
- G-CSF:
-
Granulocyte colony-stimulating factor
- ERp29:
-
Endoplasmic reticulum protein 29
- HIF-1:
-
Hypoxia-inducible factor 1
- HSP-72:
-
72 kilodalton heat shock protein
- ICH:
-
Intracerebral hemorrhage
- IGF-1:
-
Insulin-like growth factor 1
- IS:
-
Ischemic stroke
- mKitL:
-
membrane bound Kit ligand
- MMP-9:
-
Matrix metalloproteinase 9
- NO:
-
Nitric oxide
- PRDX1:
-
Peroxiredoxin 1
- r-tPA:
-
Recombinant tissue plasminogen activator
- SCF:
-
Stem cell factor
- SDF-1α:
-
stromal cell-derived factor 1α
- VEGF:
-
Vascular endothelial growth factor
- VEGFR2:
-
Vascular endothelial growth factor receptor 2
References
Agulla J, Brea D, Campos F, Sobrino T, Argibay B, Al-Soufi W, Blanco M, Castillo J, Ramos-Cabrer P (2014) In vivo theranostics at the peri-infarct region in cerebral ischemia. Theranostics 4:90–105
Arenillas JF, Sobrino T, Castillo J, Dávalos A (2007) The role of angiogenesis in damage and recovery from ischemic stroke. Curr Treat Options Cardiovasc Med 9:205–212
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69:904–910
Bogoslovsky T, Chaudhry A, Latour L, Maric D, Luby M, Spatz M, Frank J, Warach S (2010) Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 75:2059–2062
Bogoslovsky T, Spatz M, Chaudhry A, Maric D, Luby M, Frank J, Warach S (2011a) Circulating CD133+ CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients. J Transl Med 9:145
Bogoslovsky T, Spatz M, Chaudhry A, Maric D, Luby M, Frank J, Warach S, NINDS Natural History of Stroke Investigators (2011b) Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients. Stroke 42:618–625
Brea D, Sobrino T, Ramos-Cabrer P, Castillo J (2009) Reorganisation of the cerebral vasculature following ischaemia. Rev Neurol 49:645–654
Brea D, Rodríguez-González R, Sobrino T, Rodríguez-Yañez M, Blanco M, Castillo J (2011) Proteomic analysis shows differential protein expression in endothelial progenitor cells between healthy subjects and ischemic stroke patients. Neurol Res 33:1057–1063
Carenza E, Barceló V, Morancho A, Levander L, Boada C, Laromaine A, Roig A, Montaner J, Rosell A (2014) In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies. Nanomedicine 10:225–234
Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, Thomson J, Slukvin I (2009) Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559–567
Chu K, Jung KH, Lee ST, Park HK, Sinn DI, Kim JM, Kim DH, Kim JH, Kim SJ, Song EC, Kim M, Lee SK, Roh JK (2008) Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke 39:1441–1447
Endres M (2005) Statins and stroke. J Cereb Blood Flow Metab 25:1093–1110
Foubert P, Matrone G, Souttou B, Leré-Déan C, Barateau V, Plouët J, Le Ricousse-RoussanneS, Lévy BI, Silvestre JS, Tobelem G (2008) Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Circ Res 103:751–760
Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O’Rourke F, Nasser AM, Schwindt B, Todd K (2005) Endothelial progenitor cells during cerebrovascular disease. Stroke 36:151–153
Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endotelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600
Hurtado O, Pradillo JM, Alonso-Escolano D, Lorenzo P, Sobrino T, Castillo J, Lizasoain I, Moro MA (2006) Neurorepair versus neuroprotection in stroke. Cerebrovasc Dis 21(Suppl 2):54–63
Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101:18117–18122
Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE, Dzau VJ (2004) Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110:2039–2046
Krizanac-Bengez L, Mayberg MR, Janigro D (2004) The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology. Neurol Res 26:846–853
Lai WH, Ho JC, Chan YC, Ng JH, Au KW, Wong LY, Siu CW, Tse HF (2013) Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells. PLoS ONE 8:e57876
Lapergue B, Mohammad A, Shuaib A (2007) Endothelial progenitor cells and cerebrovascular diseases. Prog Neurobiol 83:349–362
Larsen K, Cheng C, Tempel D, Parker S, Yazdani S, den Dekker WK, Houtgraaf JH, de Jong R, Swager-ten Hoor S, Ligtenberg E, Hanson SR, Rowland S, Kolodgie F, Serruys PW, Virmani R, Duckers HJ (2012) Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur Heart J 33:120–128
Lloyd-Jones D et al (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:e46–e215
Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S, Bresolin N, Comi GP, Corti S (2009) Stem cell therapy in stroke. Cell Mol Life Sci 66:757–772
Mao L, Huang M, Chen SC, Li YN, Xia YP, He QW, Wang MD, Huang Y, Zheng L, Hu B (2014) Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke. CNS Neurosci Ther 20:460–468
Martí-Fàbregas J, Crespo J, Delgado-Mederos R, Martínez-Ramírez S, Peña EMarínR, Dinia L, Jiménez-Xarrié E, Fernández-Arcos A, Pérez-Pérez J, Querol L, Suárez-Calvet M, Badimon L (2013) Endothelial progenitor cells in acute ischemic stroke. Brain Behav 3:649–655
Mokin M, Khalessi AA, Mocco J, Lanzino G, Dumont TM, Hanel RA, Lopes DK, Fessler RD 2nd, Ringer AJ, Bendok BR, Veznedaroglu E, Siddiqui AH, Hopkins LN, Levy EI (2014) Endovascular treatment of acute ischemic stroke: the end or just the beginning? Neurosurg Focus 36:E5
Navarro-Sobrino M, Rosell A, Hernandez-Guillamon M, Penalba A, Ribó M, Alvarez-Sabín J, Montaner J (2010) Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res 80:317–323
Paczkowska E, Gołąb-Janowska M, Bajer-Czajkowska A, Machalińska A, Ustianowski P, Rybicka M, Kłos P, Dziedziejko V, Safranow K, Nowacki P, Machaliński B (2013) Increased circulating endothelial progenitor cells in patients with haemorrhagic and ischaemic stroke: the role of endothelin-1. J Neurol Sci 325:90–99
Park SW, Jun Koh Y, Jeon J, Cho YH, Jang MJ, Kang Y, Kim MJ, Choi C, Sook Cho Y, Chung HM, Koh GY, Han YM (2010) Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood 116:5762–5772
Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, McCoy JP, Read EJ, Khuu HM, Leitman SF, Finkel T, Cannon RO 3rd (2005) Granulocyte colony stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25:296–301
Rafii S, Heissig B, Hattori K (2002) Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther 9:631–641
Rodríguez-González R, Hurtado O, Sobrino T, Castillo J (2007) Neuroplasticity and cellular therapy in cerebral infarction. Cerebrovasc Dis 24(Suppl 1):167–180
Rufaihah AJ, Huang NF, Jamé S, Lee JC, Nguyen HN, Byers B, De A, Okogbaa J, Rollins M, Reijo-Pera R, Gambhir SS, Cooke JP (2011) Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 31:e72–79
Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154:1125–1135
Schänzer A, Wachs FP, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H, Winkler J, Aigner L, Plate KH, Kuhn HG (2004) Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 14:237–248
Sobrino T, Hurtado O, Moro MA, Rodríguez-Yáñez M, Castellanos M, Brea D, Moldes O, Blanco M, Arenillas JF, Leira R, Dávalos A, Lizasoain I, Castillo J (2007) The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 38:2759–2764
Sobrino T, Arias S, Rodríguez-González R, Brea D, Silva Y, de la ONP, Agulla J, Blanco M, Pumar JM, Serena J, Dávalos A, Castillo J (2009) High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage. J Cereb Blood Flow Metab 29:1968–1974
Sobrino T, Arias S, Pérez-Mato M, Agulla J, Brea D, Rodríguez-Yáñez M, Castillo J (2011a) Cd34+ progenitor cells likely are involved in the good functional recovery after intracerebral hemorrhage in humans. J Neurosci Res 89:979–985
Sobrino T, Rodríguez-González R, Blanco M, Brea D, Pérez-Mato M, Rodríguez-Yáñez M, Leira R, Castillo J (2011b) CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke. Neurol Res 33:572–577
Sobrino T, Blanco M, Pérez-Mato M, Rodríguez-Yáñez M, Castillo J (2012a) Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase. Eur J Neurol 19:1539–1546
Sobrino T, Pérez-Mato M, Brea D, Rodríguez-Yáñez M, Blanco M, Castillo J (2012b) Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke. J Neurosci Res 90:1788–1793
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
Thored P, Wood J, Arvidsson A, Cammenga J, Kokaia Z, Lindvall O (2007) Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 38:3032–3039
Tymianski M (2013) Novel approaches to neuroprotection trials in acute ischemic stroke. Stroke 44:2942–2950
Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:e1–e7
Werner N, Nickenig G (2006) Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol 26:257–266
Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93:e17–24
Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Eng J Med 353:999–1007
Xu Y, Liu L, Zhang L, Fu S, Hu Y, Wang Y, Fu H, Wu K, Xiao H, Liu S, Yu X, Zheng W, Feng B, Huang H (2012) Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells. PLoS ONE 7:e34321
Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322–1328
Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW (2008) Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 39:69–74
Yoo CH, Na HJ, Lee DS, Heo SC, An Y, Cha J, Choi C, Kim JH, Park JC, Cho YS (2013) Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases. Biomaterials 34:8149–8160
Zhang ZG, Chopp M (2009) Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8:491–500
Zhang ZG, Zhang L, Jiang Q, Chopp M (2002) Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral Ischemia in the adult mouse. Circ Res 90:284–288
Zhao YH, Yuan B, Chen J, Feng DH, Zhao B, Qin C, Chen YF (2013) Endothelial progenitor cells: therapeutic perspective for ischemic stroke. CNS Neurosci Ther 19:67–75
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Conclusions
Conclusions
In brief, in response to stimuli such as stroke , EPCs are mobilized from bone marrow to peripheral blood and may participate in endothelial cell repair-regeneration and in tissue neovascularization processes. In this context, experimental and human studies have shown that neovascularization is present in the adult brain exposed to ischemia and that EPCs participate in cerebral neovascularization processes. Finally, we and others have observed that a higher increment in the number of circulating EPCs is associated with a better outcome in patients with stroke. Taken together, these findings suggest that EPCs may mediate neurorepair processes after stroke, and that exogenous supplementation or endogenous stimulation of EPCs have a great therapeutic potential for stroke. However, larger clinical trials are needed to evaluate the safety and efficacy of EPC transplantation for treating stroke. Furthermore, how to improve the strategies in order to maximize the endogenous stimulation of EPCs deserves also further studies.
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sobrino, T., Campos, F., Castillo, J. (2015). The Role of Endothelial Progenitor Cells in Stroke. In: Zhao, LR., Zhang, J. (eds) Cellular Therapy for Stroke and CNS Injuries. Springer Series in Translational Stroke Research. Springer, Cham. https://doi.org/10.1007/978-3-319-11481-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-11481-1_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11480-4
Online ISBN: 978-3-319-11481-1
eBook Packages: MedicineMedicine (R0)